Year |
Citation |
Score |
2012 |
Watters RJ, Kester M, Tran MA, Loughran TP, Liu X. Development and use of ceramide nanoliposomes in cancer. Methods in Enzymology. 508: 89-108. PMID 22449922 DOI: 10.1016/B978-0-12-391860-4.00005-7 |
0.346 |
|
2011 |
Sudol M, Fritz JL, Tran M, Robertson GP, Ealy JB, Katzman M. Evaluation of a system to screen for stimulators of non-specific DNA nicking by HIV-1 integrase: application to a library of 50,000 compounds. Antiviral Chemistry & Chemotherapy. 22: 67-74. PMID 21984686 DOI: 10.3851/Imp1857 |
0.513 |
|
2011 |
Jiang Y, DiVittore NA, Kaiser JM, Shanmugavelandy SS, Fritz JL, Heakal Y, Tagaram HR, Cheng H, Cabot MC, Staveley-O'Carroll KF, Tran MA, Fox TE, Barth BM, Kester M. Combinatorial therapies improve the therapeutic efficacy of nanoliposomal ceramide for pancreatic cancer. Cancer Biology & Therapy. 12: 574-85. PMID 21795855 DOI: 10.4161/Cbt.12.7.15971 |
0.357 |
|
2011 |
Soehnlen MK, Tran MA, Lysczek HR, Wolfgang DR, Jayarao BM. Identification of novel small molecule antimicrobials targeting Mycoplasma bovis. The Journal of Antimicrobial Chemotherapy. 66: 574-7. PMID 21393230 DOI: 10.1093/Jac/Dkq503 |
0.325 |
|
2010 |
Sudol M, Tran M, Nowak MG, Flanagan JM, Robertson GP, Katzman M. A nonradioactive plate-based assay for stimulators of nonspecific DNA nicking by HIV-1 integrase and other nucleases. Analytical Biochemistry. 396: 223-30. PMID 19748478 DOI: 10.1016/J.Ab.2009.09.012 |
0.521 |
|
2009 |
Tran MA, Watts RJ, Robertson GP. Use of liposomes as drug delivery vehicles for treatment of melanoma. Pigment Cell & Melanoma Research. 22: 388-99. PMID 19493316 DOI: 10.1111/J.1755-148X.2009.00581.X |
0.513 |
|
2008 |
Tran MA, Gowda R, Sharma A, Park EJ, Adair J, Kester M, Smith NB, Robertson GP. Targeting V600EB-Raf and Akt3 using nanoliposomal-small interfering RNA inhibits cutaneous melanocytic lesion development. Cancer Research. 68: 7638-49. PMID 18794153 DOI: 10.1158/0008-5472.Can-07-6614 |
0.572 |
|
2008 |
Tran MA, Smith CD, Kester M, Robertson GP. Combining nanoliposomal ceramide with sorafenib synergistically inhibits melanoma and breast cancer cell survival to decrease tumor development. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 3571-81. PMID 18519791 DOI: 10.1158/1078-0432.Ccr-07-4881 |
0.557 |
|
2006 |
Sharma A, Tran MA, Liang S, Sharma AK, Amin S, Smith CD, Dong C, Robertson GP. Targeting mitogen-activated protein kinase/extracellular signal-regulated kinase kinase in the mutant (V600E) B-Raf signaling cascade effectively inhibits melanoma lung metastases. Cancer Research. 66: 8200-9. PMID 16912199 DOI: 10.1158/0008-5472.Can-06-0809 |
0.572 |
|
Show low-probability matches. |